Close Menu

clinical lab errors

The Cancer Journal documented 25 cases where inappropriate tests were ordered, variants were interpreted incorrectly, and wrong results were reported to patients. 

A study led by Johns Hopkins describes a method for automating slow, inaccurate manual chart review when searching for signs of misdiagnosis.

The company estimates that the quality control issue resulted in between two and 15 patients getting a false negative result. 

To Catch the Swap

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

Regulators have proposed banning Theranos CEO from owning or operating any lab for two years, the Wall Street Journal reports.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.